A global pharmaceutical company's R&D and clinical strategy teams struggled to advance drugs to the next clinical phase without a structured evaluation and approval process. Cross-functional inputs were required from multiple teams for each drug evaluation, with no way to identify or fill gaps. The executive approval process lacked structure and took too long, delaying clinical timelines.
A structured decision framework established all key clinical trial requirements, enabling teams to provide input on subject areas and quickly identify information gaps. The platform delivered a collaborative decision flow gathering multi-team inputs with explicit structure for drug evaluation and executive approval with clear accountability.
Results
50% faster time to decision
All clinical trial requirements were captured upfront, eliminating gaps in the evaluation process. Cross-functional teams aligned faster by contributing input through a single coordinated decision flow. Information gaps were quickly identified and resolved. Structuring the drug-to-trial decision process with explicit input requirements and clear accountability cut decision time by 50% and generated $1.5M in value from faster clinical trial initiation.